4th Annual Biosimilars Summit

Vonlanthen Group is pleased to invite you to the 4th Annual Biosimilars Summit, scheduled for the 7th – 8th of June, 2018 in Vienna.

This 4th Annual Biosimilars Summit brings together industry experts to explore the strategies and insights into designing new biosimilar development programs, analytical requirements, clinical advancements, and new solutions for successful implementation in the market.

This summit offers participants a fantastic opportunity to engage in interactive networking, learn best practices, maintain a business relationship, meet new clients.

We look forward to welcoming you at the Summit in Vienna in June!

Key Practical Learning Points of the Summit:

  • Regulatory challenges in global biosimilars development, updates on regulatory guidelines
  • Successful commercialization strategies
  • Pricing & Reimbursement
  • Payers perspectives on biosimilars
  • Value drivers for biosimilars
  • Latest achievements in Biosimilars in therapeutic areas
  • Innovations in clinical trials
  • Patient safety top concern with Biosimilars
  • Bioanalytical characterization: Lessons learned from recent approvals
  • Risk management and Pharmacovigilance plan

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Heads, Lab Heads, Leaders, and Managers specialising in:

  • Biologics/ Biotechnology/ Biogenerics
  • Biopharmaceuticals
  • Legal Affairs
  • Intellectual Property
  • Pricing and Reimbursement
  • Clinical Immunology
  • Regulatory Compliance
  • R&D
  • Preclinical and Clinical Development
  • New Product Development
  • Quality Affairs/ Quality Control
  • Pharmacovigilance


  • Clinical Immunology
  • Oncology
  • Immunology
  • Infection and Immunity
  • Drug Safety
  • Risk Management
  • Preclinical Development
  • Clinical Program
  • Therapeutic Areas
  • Personalised Medicine
  • Business Development
  • Portfolio Planning
  • Vaccines Development
  • Regulatory Affairs
  • Scientific Affairs
  • Pharmacovigilance
  • Validation
  • Global Strategy
  • Analytical Characterisation
  • Antibody Engineering
  • Antibody Discovery
  • Formulation Development
  • Outsourcing